glp-1 receptor brain The gut-brain axis for the actions of glucagon-like peptide-1. After a Glucagon-like Peptide-1 and the Central/Peripheral
Description
Switching between medications requires understanding the conversion dosing and ideally medical supervision

Semaglutide to tirzepatide: the most common switch This is the most well-documented transition

For those comparing options, our semaglutide vs tirzepatide vs retatrutide comparison covers the differences in mechanism, efficacy, and side effect profiles

Uncommon: Constipation, skin reactions, arthralgia, hypoglycaemia, peripheral oedema

All FDA-approved GLP-1 medications are administered via subcutaneous injection or oral tablets, requiring prescription from licensed healthcare providers
